JSPR
Jasper Therapeutics Inc
0.6091$
+4.1%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | – | 100.0% | 100.0% | – | – | – | |
| – | – | 9.1% | 9.7% | – | – | – | |
| – | – | -9.1% | -9.7% | – | – | – | |
| – | – | 410.3% | 256.3% | – | – | – | |
| – | – | 184.2% | 122.6% | – | – | – | |
| – | – | 594.5% | 378.9% | – | – | – | |
| – | – | -594.5% | -378.9% | – | – | – | |
| – | – | 100.0% | 100.0% | – | – | – | |
| – | – | -494.5% | -278.9% | – | – | – | |
| – | – | -17.7% | -100.0% | – | – | – | |
| – | – | -494.5% | -278.9% | – | – | – | |
| – | – | -488.4% | -271.7% | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.